6.01 Total Revenues 298.26 604.18 1,018.60 1,620.84 797.50 Costs 203.56 321.20 580.70 856.82 380.02 Selling And Administrative Expenses 82.93 57.10 126.84 433.21 329.69 Total Cost And Expenses 287.42

673.64 664.13 793.69 Other Income 26.64 169.36 185.43 19.16 40.60 Total Revenues 368.02 493.19 860.62 683.30 836.16 Costs 208.19 203.39 406.29 415.60 542.68 Selling And Administrative Expenses 103.78

Consolidate Consolidate Consolidate Revenue From Operations 93.77 253.84 394.87 857.61 457.06 Other Income 4.83 37.78 103.46 53.92 35.44 Total Revenues 98.60 291.63 498.32 911.53 492.82 Costs 77.91 300.49

Revenue From Operations 1,084.34 1,324.04 2,473.02 2,844.06 2,336.69 Other Income 4.17 7.95 14.89 15.70 17.83 Total Revenues 1,088.52 1,333.04 2,489.95 2,862.99 2,354.52 Costs 982.68 1,128.12 2,156.73

Other Income 5.10 2.71 22.98 28.81 37.82 Total Revenues 1,277.43 1,109.26 2,312.01 2,090.66 1,243.84 Costs 1,168.37 1,013.55 2,115.54 1,835.85 1,010.75 Selling And Administrative Expenses 54.20 43.67

have been issued. For the good corporate governance, the Board approved the cancellation of the approval to issue the ESOP warrants up to a total of 99,236,870 units to the Company’s directors and

Revenue From Operations 1,185.78 1,164.74 1,383.18 1,945.98 Other Income 26.07 45.83 46.11 54.21 Total Revenues 1,211.86 1,210.57 1,429.29 2,000.19 Costs 765.90 727.79 849.78 1,119.43 Selling And

Income 133.18 307.06 241.47 241.88 Total Revenues 25,937.13 18,924.82 17,971.82 18,535.17 Costs 20,578.01 15,737.30 14,910.74 15,760.87 Selling And Administrative Expenses 2,835.55 2,037.80 1,879.08

)  Accounting Type Consolidate Consolidate Consolidate Consolidate Revenue From Operations 1,065.49 1,409.84 1,198.27 2,169.43 Other Income 31.36 53.15 47.23 13.81 Total Revenues 1,097.38 1,464.38 1,247.74

39.08 16.70 26.86 Total Revenues 2,136.92 1,848.58 2,072.18 1,967.08 Costs 1,610.00 1,496.81 1,647.83 1,572.51 Selling And Administrative Expenses 148.91 173.84 168.24 228.69 Total Cost And Expenses